BioMAS Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Employees
  • 34

Employees

  • Latest Deal Type
  • Corporate

  • Financing Rounds
  • 1

BioMAS General Information

Description

Developer of tellurium based drugs. The company engages in invention, development and commercialization of tellurium based compounds.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Corporate Office
  • The Hebrew University of Jerusalem
  • Edmond J. Safra Campus, Givat Ram, High-Tech Village
  • Jerusalem 91390
  • Israel
+972 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioMAS Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioMAS‘s full profile, request access.

Request a free trial

BioMAS Patents

BioMAS Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2442817-A1 Tellurium-containing compounds for treating viral infections Inactive 16-Jun-2009 000000000
US-20120157519-A1 Tellerium-containing compounds for treating viral infections Inactive 16-Jun-2009 000000000
US-20110275709-A1 Tellurium-containing compounds for affecting male's fertility following chemotherapy and/or radiotherapy Inactive 08-Jan-2009 000000000
EP-2385758-A1 Tellurium-containing compounds for affecting female's reproductive system following chemotherapy and/or radiotherapy Inactive 08-Jan-2009 0000000000
US-20120035260-A1 Tellurium-containing compounds for affecting female's reproductive system following chemotherapy and/or radiotherapy Inactive 08-Jan-2009 A61K31/095
To view BioMAS’s complete patent history, request access »

BioMAS Executive Team (3)

Name Title Board Seat Contact Info
Michael Albeck Ph.D Co-Founder and Inventor
Benjamin Sredni Ph.D Co-Founder and Inventors
You’re viewing 2 of 3 executive team members. Get the full list »

BioMAS Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioMAS Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BioMAS‘s full profile, request access.

Request a free trial

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »